TokenPost·
Novartis Is Largely Abandoning Ionis Heart Drug After Trial Failure
The RNA-targeting candidate failed in a late-stage trial last September.
More news
- TokenPostEther Trades at $2,109.46 After a 5.42% 24-Hour Decline
- TokenPostVenice Adds OpenAI Image Models With Anonymous Access and Editing
- Crypto BriefingUtilities race for second-hand gas turbines as AI power demand surges
- CoinDeskSpaceX proposes a $24 billion Texas supercomputer worth 17 times its bitcoin pile
- crypto.newsWhy is Ethereum price down today, November 9?
- TokenPostBRBI BR Partners S.A. Posts R$0.07 Q3 EPS as Revenue Falls 7.5%